- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Company Founded by 2006 Nobel Prize co-recipient Dr. Craig Mello to Lease Space
Gateway Park announced today that RXi Pharmaceuticals has signed a 20-month lease to locate in the WPI Life Sciences and Bioengineering Center with the option to become the lead tenant of a future 100,000-square-foot building planned for construction at Gateway Park. The company, founded by Nobel Laureate Craig Mello, PhD, is one of several firms that have signed an Indication of Interest as potential future tenants of the rapidly expanding Gateway Park.
RXi Pharmaceuticals was created to develop therapeutics for the treatment of human disease employing the RNA interference (RNAi) technology co-discovered by Dr. Mello, of the University of Massachusetts Medical School. RNAi technology can help determine the function of particular genes in the body and also potentially lead to the development of new RNAi-based drugs. Using RNAi to turn off defective genes opens the door for an entirely new class of drugs to potentially treat cancer, diabetes, Alzheimer's, ALS, and many other diseases.
According to D'Anne Hurd, Vice President for Business Development at Gateway Park, "Gateway Park offered all of the advantages RXi Pharmaceuticals was looking for in a location - state-of-the-art laboratories, beautiful office space, access to shared equipment, support infrastructure, and proximity to their founding scientist's laboratories in Worcester, MA."
As a tenant in the new Life Sciences and Bioengineering Center, RXi Pharmaceuticals will be adjacent to dozens of WPI faculty members and students, working in interdisciplinary research centers and programs, who are conducting basic and applied research and working to translate their discoveries into viable life-sciences-based products and companies. The WPI Life Sciences and Bioengineering Center is the first building to be completed at Gateway Park and it hosts advanced research in such areas as regenerative medicine, molecular nanotechnology and biosensors, plant systems, tissue engineering, and untethered healthcare.
"RXi is an ideal match for what Gateway Park can provide to growing, creative life sciences companies," said WPI President and CEO Dennis Berkey. "We are honored that RXi Pharmaceuticals is interested in joining the unique community of scientists, entrepreneurs and innovators at Gateway Park. Their interest in becoming the lead tenant of the 100K sq ft. building is a testament to the growing momentum at Gateway Park."
About RXi Pharmaceuticals
RXi is a biopharmaceutical research and development company that focuses on developing RNAi-based therapeutics for the treatment of human disease. The company was founded by RNAi pioneers Craig Mello, Ph.D., 2006 Nobel Laureate for discovering RNAi and inventing RNAi therapeutics, Tariq M. Rana, Ph.D., inventor of fundamental technology for stabilizing RNAi and of RNAi nanotransporters, Greg Hannon, Ph.D., discoverer of RNAi mechanism (RISC) and short hairpin RNAi (shRNAi), and Michael Czech, Ph.D., a leader in the application of RNAi to diabetes and obesity. Mello, Rana and Czech are on the faculty at the University of Massachusetts Medical School in Worcester, MA; Hannon is at Cold Spring Harbor Laboratory in New York.
About Gateway Park
Gateway Park is a joint venture of Worcester Polytechnic Institute (WPI) and the Worcester Business Development Corporation (WBDC). Located in Worcester, near the intersection of I-190 and I-290, Gateway Park is designed as a 12 acre, mixed-use destination for life sciences and biotech companies and the people who work for them. At completion, the project will include five life sciences buildings totaling 500,000 square feet of flexible, adaptable lab space designed to meet the needs of research organizations, 241,000 sq. ft. of market rate, loft condominiums as well as several planned retail establishments. WPI is also exploring the possibility of graduate student housing on one of the sites. Gateway Park is part of the larger 55-acre Gateway redevelopment district. It is currently home to numerous businesses, offices, restaurants, and business services, as well as a Courtyard by Marriott hotel.
About Worcester Polytechnic Institute
Founded in 1865 in Worcester, Mass., WPI was one of the nation's first engineering and technology universities. WPI's 18 academic departments offer more than 50 undergraduate and graduate degree programs in science, engineering, technology, management, the social sciences, and the humanities and arts, leading to the BA, BS, MS, ME, MBA and PhD. WPI's world-class faculty work with students in a number of cutting-edge research areas, leading to breakthroughs and innovations in such fields as biotechnology, fuel cells, and information security, materials processing, and nanotechnology. Students also have the opportunity to make a difference to communities and organizations around the world through the university's innovative Global Perspective Program. There are more than 20 WPI project centers throughout North America and Central America, Africa, Australia, Asia, and Europe.
For more information, please click here
Eileen Brangan Mell
Director of Public Relations
Copyright © Worcester Polytechnic InstituteIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Albertan Science Lab Opens in India May 7th, 2016
SUNY Poly Partnership with Japan's New Energy and Industrial Development Organization Drives Investment in and Installation of Emerging ‘Green’ Technologies at World-Class 'Zero Energy Nano' Building March 22nd, 2016
Composite Pipe Long Term Testing Facility February 10th, 2016